Cargando…

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Liver transplantation (LT) is the optimal therapeutic option for patients with liver cirrhosis and hepatocellular carcinoma (HCC). Due to universal donor shortage, only the patients with limited tumor burden (under the so-called Milan criteria) are considered as potential candidates for LT in most i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amado, Víctor, Rodríguez-Perálvarez, Manuel, Ferrín, Gustavo, De la Mata, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306074/ https://www.ncbi.nlm.nih.gov/pubmed/30613572 http://dx.doi.org/10.2147/JHC.S174549

Ejemplares similares

Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
por: Ferrín, Gustavo, et al.
Publicado: (2020)

Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation
por: Amado, Víctor, et al.
Publicado: (2021)

mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence
por: Guerrero, Marta, et al.
Publicado: (2019)

Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
por: Espejo-Cruz, María Lola, et al.
Publicado: (2021)

Liver transplantation: immunosuppression and oncology
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2014)

Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact
por: Pérez, Pablo, et al.
Publicado: (2017)

Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Selection criteria in liver transplantation for hepatocellular carcinoma: an ongoing evolution
por: Line, Pål-Dag
Publicado: (2022)

Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Rodríguez-Perálvarez, Manuel
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria
por: Ince, Volkan, et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression
por: González-Rubio, Sandra, et al.
Publicado: (2016)

Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation
por: Lei, Jianyong, et al.
Publicado: (2017)

The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
por: Chen, Jun, et al.
Publicado: (2014)

Enumeration and Characterization of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Espejo-Cruz, María L., et al.
Publicado: (2023)

Is liver transplantation superior to liver resection for hepatocellular carcinoma within Milan criteria?
por: Feng, Qingbo, et al.
Publicado: (2022)

Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
por: Pavel, Mihai-Calin, et al.
Publicado: (2018)

Prognostic role of selection criteria for liver transplantation in patients with hepatocellular carcinoma: a network meta-analysis
por: Lozanovski, Vladimir J, et al.
Publicado: (2022)

Reply to: “Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients”
por: Rodríguez-Perálvarez, Manuel, et al.
Publicado: (2021)

LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA
por: SÁ, Gustavo Pilotto D., et al.
Publicado: (2016)

Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology
por: McVey, John C, et al.
Publicado: (2020)

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
por: López-Cánovas, Juan L., et al.
Publicado: (2023)

The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer
por: Grąt, Michał, et al.
Publicado: (2016)

Can living donor liver transplantation offer similar outcomes to deceased donor liver transplantation using expanded selection criteria for hepatocellular carcinoma?
por: Chen, Li-Ping, et al.
Publicado: (2015)

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
por: López‐Cánovas, Juan L., et al.
Publicado: (2022)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
por: Liu, Fei, et al.
Publicado: (2012)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Liang, Hsin-Rou, et al.
Publicado: (2021)

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome
por: Kornberg, A.
Publicado: (2014)

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Combination of Morphologic Criteria and α-Fetoprotein in Selection of Patients With Hepatocellular Carcinoma for Liver Transplantation Minimizes the Problem of Posttransplant Tumor Recurrence
por: Grąt, Michał, et al.
Publicado: (2014)

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021)

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
por: Brusset, Bleuenn, et al.
Publicado: (2021)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
por: Hu, Zhenhua, et al.
Publicado: (2014)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
por: Beumer, Berend R., et al.
Publicado: (2022)

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients
por: Aguiar, Diego, et al.
Publicado: (2017)

Scoring Selection Criteria Including Total Tumour Volume and Pretransplant Percentage of Lymphocytes to Predict Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Li, Chuan, et al.
Publicado: (2013)

Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma
por: Herrero, Astrid, et al.
Publicado: (2022)

Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality
por: Jurado-García, Juan, et al.
Publicado: (2016)

Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion
por: Chan, See Ching, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qcuvi86idg7nqg1gmt6ea5vvk7